Abingdon Health Plc (LON:ABDX – Get Free Report)’s stock price traded up 6% on Wednesday . The company traded as high as GBX 8.75 ($0.11) and last traded at GBX 8.75 ($0.11). 15,850 shares were traded during trading, a decline of 93% from the average session volume of 223,908 shares. The stock had previously closed at GBX 8.25 ($0.11).
Abingdon Health Stock Performance
The company has a debt-to-equity ratio of 46.64, a quick ratio of 1.96 and a current ratio of 1.95. The stock’s fifty day moving average is GBX 9.47 and its two-hundred day moving average is GBX 10.15. The firm has a market cap of £16.57 million, a price-to-earnings ratio of -899.00 and a beta of 0.13.
About Abingdon Health
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.
Featured Stories
- Five stocks we like better than Abingdon Health
- How to Find Undervalued Stocks
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- What is Short Interest? How to Use It
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
